Gregor Jordan

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

Alexander Röth, J Nishimura, Zsolt Nagy et al. · Blood · 2020 · 130 citations · Full text

Life Sciences, Hematology, Immunology +12

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

Martina Geiger, Kay‐Gunnar Stubenrauch, Johannes Sam et al. · Nature Communications · 2020 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +17

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 &amp; CAR-T Immunogenicity; PCR &amp; Vaccine Assay Performance; ADA Assay Comparability &amp; Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)

LiNa Loo, Shannon Harris, Mark Milton et al. · Bioanalysis · 2022 · 36 citations · Full text

Medicine, Biomedical Sciences, Biotechnology +16

Correlation of in vivo and in vitro release data for rh-INFα lipid implants

Martin E. Schwab, Eckhard Wolf, Gregor Jordan et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2008 · 30 citations

Pharmacy, Bioengineering, Pharmaceutics +12

The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance

Eugenia Opolka-Hoffmann, Gregor Jordan, Michael B. Otteneder et al. · mAbs · 2021 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17